(NaturalNews)
(Natural News) Since 2016, pharmaceutical giant AbbVie has generated more than $114 billion in revenue from the sale of its anti-inflammatory drug Humira. That same year, Humira was supposed to go off-patent and become generic – meaning it would have cost a whole lot less for consumers – but because of patent manipulation, AbbVie has been … [Read More…] |
Related posts:
UK Tube Station Machete Attack is an Islamophobic Hoax
Israel wants another billion dollars from the U.S.
Israeli military's $2 billion future transport helicopter is allergic to dust
Britain and Saudi Arabia: Partners in High Crimes
Multi-Billion Dollar “Directed Energy Weapons Market For Military & “Civilian Use...
The Real Reason To Hug a Tree
Views: 0